• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 3.0/15; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 3.0/15; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419116
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/05/2022
Event Type  malfunction  
Manufacturer Narrative
Combination product: yes.
 
Event Description
During treatment of a total occlusion with thrombus aspiration and a competitors balloon, the balloon ruptured.Subsequently, the orsiro mission drug-eluting stent system was inserted, but it could not be expanded at all.So the delivery catheter was removed from the body.Outside the body, a leakage of the balloon was confirmed.Another stent was used to complete the intervention.
 
Manufacturer Narrative
Combination product: yes.The returned device was subjected to a detailed technical analysis and the corresponding product release documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.The technical investigation revealed that the balloon is still well folded.Contrast medium was found inside of the inflation lumen and the balloon lumen.The stent is still crimped on the balloon between the x-ray markers and the crimped diameter is still in specification.The distal balloon shoulder shows a damage in the shape of a small cut in diagonal direction.This cut is reaching through the wall of the balloon shoulder, causing a leakage.The leakage of the balloon most likely contributed to the inability to expand the stent.However, the cause of the damage of the balloon shoulder could not be clarified.Review of the product release documentation verified that the instrument detailed above was manufactured according to specifications.The device fulfilled all the requirements of in-process and final inspection.In addition to visual inspections each instrument is tested for air tightness by means of a pressure test and a helium leak test.The instrument was delivered in a leak-proof condition.Based on the conducted investigations no material or manufacturing related root cause could be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 3.0/15
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key16019921
MDR Text Key306019058
Report Number1028232-2022-06553
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130441767
UDI-Public(01)07640130441767(17)2404
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility,Company Representative,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number419116
Device Catalogue NumberSEE MODEL NO.
Device Lot Number03226077
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/14/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-